|
PSAT1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.233700E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.106300E-02 |
| Normal-vs-Stage2 |
1.188050E-02 |
| Normal-vs-Stage3 |
1.731630E-02 |
| Normal-vs-Stage4 |
2.990600E-01 |
| Stage1-vs-Stage2 |
7.751900E-02 |
| Stage1-vs-Stage3 |
3.782700E-04 |
| Stage1-vs-Stage4 |
1.751690E-02 |
| Stage2-vs-Stage3 |
2.178400E-03 |
| Stage2-vs-Stage4 |
5.740900E-03 |
| Stage3-vs-Stage4 |
7.482000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.049200E-01 |
| Normal-vs-AfricanAmerican |
3.92639999999833E-05 |
| Normal-vs-Asian |
8.638000E-01 |
| Caucasian-vs-AfricanAmerican |
2.350800E-04 |
| Caucasian-vs-Asian |
9.517600E-01 |
| AfricanAmerican-vs-Asian |
4.719900E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.468800E-01 |
| Normal-vs-Female |
1.993820E-02 |
| Male-vs-Female |
7.884100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.600800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.650800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.573560E-01 |
| Normal-vs-Age(81-100Yrs) |
6.000200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.340200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.935000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.159900E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.270000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.202400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.979400E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.767700E-02 |
| Classical-VS-Follicular |
2.823900E-04 |
| Classical-VS-Other |
6.364400E-01 |
| Classical-VS-Normal |
8.559400E-01 |
| Tall-VS-Follicular |
2.098099999992E-05 |
| Tall-VS-Other |
3.560800E-01 |
| Tall-VS-Normal |
8.045900E-02 |
| Follicular-VS-Other |
4.012000E-01 |
| Follicular-VS-Normal |
1.382710E-04 |
| Other-VS-Normal |
6.378000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.578900E-03 |
| Normal-vs-N1 |
4.034200E-01 |
| N0-vs-N1 |
1.071600E-02 |
|
|
